Cargando…

New directions in hepatitis B therapy research

Chronic hepatitis B treatment is available for a long period, allowing disease control and infection suppression, but it is rarely responsible for HBsAg clearance. None of the drugs available aim at cccDNA, the obstacle in HBV infection eradication. Complications related to CHB, such as liver insuff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lewandowska, Marta, Piekarska, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2017
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649484/ https://www.ncbi.nlm.nih.gov/pubmed/29062901 http://dx.doi.org/10.5114/ceh.2017.68831

Ejemplares similares

Recommendations for the treatment of hepatitis B in 2017
por: Flisiak, Robert, et al.
Publicado: (2017)

Hepatitis B Core-Related Antigen and New Therapies for Hepatitis B
por: Watanabe, Takehisa, et al.
Publicado: (2021)

Diagnostic value of optimised real-time sonoelastography in the assessment of liver fibrosis in chronic hepatitis B and C
por: Kalita, Katarzyna, et al.
Publicado: (2016)

Efficacy and direct costs of chronic hepatitis C treatment with first generation NS3/4A protease inhibitors in a real life population
por: Piekarska, Anna, et al.
Publicado: (2016)

Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2023
por: Tomasiewicz, Krzysztof, et al.
Publicado: (2023)

Hepatitis B Virus Research in South Africa
por: Maepa, Mohube B., et al.
Publicado: (2022)

Mouse models for hepatitis B virus research
por: Hwang, Jeong-Ryul, et al.
Publicado: (2018)

The influence of NAFLD on the risk of atherosclerosis and cardiovascular diseases
por: Wójcik-Cichy, Kamila, et al.
Publicado: (2018)

Surveillance for portal hypertension in the course of liver cirrhosis
por: Piekarska, Anna, et al.
Publicado: (2018)

Pangenotypic triple versus double therapy in HCV-infected patients after prior failure of direct-acting antivirals
por: Flisiak, Robert, et al.
Publicado: (2023)

New Directions for SMA Therapy
por: Messina, Sonia
Publicado: (2018)

New Directions in the Therapy of Glioblastoma
por: Szklener, Katarzyna, et al.
Publicado: (2022)

A new direction for Alzheimer's research
por: Weinstein, James D.
Publicado: (2018)

Hepatitis B Treatment: What We Know Now and What Remains to Be Researched
por: Suk‐Fong Lok, Anna
Publicado: (2018)

A new model to predict response to direct-acting antiviral therapy in decompensated cirrhotics due to hepatitis C virus
por: Debnath, Prasanta, et al.
Publicado: (2020)

Novel Therapies of Hepatitis B and D
por: Khan, Iman Waheed, et al.
Publicado: (2021)

New Biomarkers of Chronic Hepatitis B
por: Mak, Lung-Yi, et al.
Publicado: (2019)

Hepatitis C and hepatitis B virus infection in hemodialysis patients after nationwide direct antiviral agents therapy—experience of 10 Romanian HD centers
por: Marc, Luciana, et al.
Publicado: (2023)

Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C
por: Brzdęk, Michał, et al.
Publicado: (2023)

Control of HBV infection in HIV/HBV co-infected patients treated with antiretroviral therapy – experience of Lodz Centre
por: Wlazłowska, Ewelina, et al.
Publicado: (2022)

Prevalence of hepatitis C virus infection in patients hospitalised for ischemic heart disease versus controls – PRO-CARDIO-C study
por: Piekarska, Anna, et al.
Publicado: (2019)

Searching for the optimal population for hepatitis C virus screening in Poland
por: Piekarska, Anna, et al.
Publicado: (2020)

CD4(+) T Cells in Chronic Hepatitis B and T Cell-Directed Immunotherapy
por: Buschow, Sonja I., et al.
Publicado: (2021)

Time for an active antiviral therapy for hepatitis B: An update on the management of hepatitis B virus infection
por: Chae, Hee Bok, et al.
Publicado: (2007)

Vertical transmission of hepatitis B virus: propositions and future directions
por: Liu, Jin-Feng, et al.
Publicado: (2021)

Current Antiviral Therapy for Chronic Hepatitis B
por: Lim, Young-Suk, et al.
Publicado: (2004)

Antiviral therapy for chronic hepatitis B in China
por: Zheng, Xin, et al.
Publicado: (2014)

Immune therapies against chronic hepatitis B
por: Akbar, Sheikh Mohammad Fazle, et al.
Publicado: (2022)

Desensitization to biological agents used in rheumatology
por: Makowska, Joanna, et al.
Publicado: (2020)

β-Cell Dysfunction, Hepatic Lipid Metabolism, and Cardiovascular Health in Type 2 Diabetes: New Directions of Research and Novel Therapeutic Strategies
por: Al-Mrabeh, Ahmad
Publicado: (2021)

New Approaches to the Treatment of Chronic Hepatitis B
por: Alexopoulou, Alexandra, et al.
Publicado: (2020)

Where to Next? Research Directions after the First Hepatitis C Vaccine Efficacy Trial
por: Phelps, Christopher C., et al.
Publicado: (2021)

Best therapy for the easiest to treat hepatitis C virus genotype 1b-infected patients
por: Zarębska-Michaluk, Dorota, et al.
Publicado: (2022)

New hepatitis C therapies in clinical development
por: Vermehren, Johannes, et al.
Publicado: (2011)

New Therapies of Liver Diseases: Hepatic Encephalopathy
por: Mangini, Chiara, et al.
Publicado: (2021)

Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection
por: Knolle, Percy A., et al.
Publicado: (2021)

Chitin and Chitosan as Polymers of the Future—Obtaining, Modification, Life Cycle Assessment and Main Directions of Application
por: Piekarska, Klaudia, et al.
Publicado: (2023)

Animal Models of Hepatitis B Virus Infection–Success, Challenges, and Future Directions
por: Liu, Yongzhen, et al.
Publicado: (2021)

ASSESSMENT OF INTAKE AND NUTRITIONAL STATUS OF VITAMIN B(1), B(2), AND B(6) IN MEN AND WOMEN WITH DIFFERENT PHYSICAL ACTIVITY LEVELS
por: Malara, M., et al.
Publicado: (2013)

Direct-Acting Antivirals and the Risk of Hepatitis B Reactivation in Hepatitis B and C Co-Infected Patients: A Systematic Review and Meta-Analysis
por: Oh, Joo Hyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qu5hnit61q745aqppgqnksi5i8